JBIO vs EWTX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 13, 2026

JBIO

30.2
AI Score
VS
EWTX Wins

EWTX

37.0
AI Score

Investment Advisor Scores

JBIO

30score
Recommendation
SELL

EWTX

37score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric JBIO EWTX Winner
Net Income -131.19M 1.06B EWTX
Operating Income -142.00M -162.20M JBIO
ROE -28.8% 64.9% EWTX
ROA -27.0% 59.5% EWTX
Total Assets 486.39M 1.78B EWTX
Cash 80.39M 68.68M JBIO
Current Ratio 16.03 12.30 JBIO
Free Cash Flow -96.84M -163.61M JBIO

Relative Price Performance (Last 90 Days)

JBIO 1M: +17.3% · 3M: -31.2% EWTX 1M: +20.2% · 3M: +4.3%

Current Technical Phase

JBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 58

RSI (14): 58.0 · Price: $16.14

EWTX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 62

RSI (14): 61.8 · Price: $45.93

Fundamentals Snapshot

Metric JBIO EWTX
Market Cap — —
Forward P/E -6.1 -24.3
Trailing P/E — 5.5
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin — —
Operating Margin 0.0% 0.0%
EPS -1.92 8.38
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, EWTX is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.